# Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma

> **NCT01446809** · NA · COMPLETED · sponsor: **University of Washington** · enrollment: 23 (actual)

## Conditions studied

- Stage IIA Adult Soft Tissue Sarcoma
- Stage III Adult Soft Tissue Sarcoma
- Stage IV Adult Soft Tissue Sarcoma

## Interventions

- **DRUG:** Doxorubicin Hydrochloride
- **RADIATION:** External Beam Radiation Therapy
- **DRUG:** Ifosfamide
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Pazopanib Hydrochloride
- **OTHER:** Pharmacological Study
- **OTHER:** Placebo
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT01446809
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01446809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01446809, "Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01446809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*